Suppr超能文献

系统性硬化症患者中α-防御素水平升高与间质性肺炎的关联。

Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis.

作者信息

Sakamoto Noriho, Kakugawa Tomoyuki, Hara Atsuko, Nakashima Shota, Yura Hirokazu, Harada Tatsuhiko, Ishimoto Hiroshi, Yatera Kazuhiro, Kuwatsuka Yutaka, Hara Toshihide, Ichinose Kunihiro, Obase Yasushi, Ishimatsu Yuji, Kohno Shigeru, Mukae Hiroshi

机构信息

Second Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.

Department of Respiratory Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

出版信息

Respir Res. 2015 Dec 10;16:148. doi: 10.1186/s12931-015-0308-1.

Abstract

BACKGROUND

Interstitial lung disease (ILD) is the leading cause of mortality in patients with systemic sclerosis (SSc). Although the pathogenesis of SSc-ILD is not well understood, neutrophils may play a pivotal role in this process. Neutrophils store azurophil granules that contain defensins, antimicrobial peptides that function in regulating the inflammatory response, and IL-8, a potent chemoattractant for neutrophils. The present study evaluated the levels of defensins and IL-8 in patients with SSc-ILD to determine their roles in disease pathogenesis.

METHODS

Defensins (also known as human neutrophil peptides, HNPs) and IL-8 levels were measured in the serum and bronchoalveolar lavage fluid (BALF) of 33 patients with SSc-ILD and in 20 healthy controls by using ELISA.

RESULTS

BALF analysis revealed a significant increase in HNPs in SSc-ILD patients (median; 240.0 pg/mL) than that of healthy controls (79.7 pg/mL). Additionally, IL-8 levels were higher in SSc-ILD patient serum and BALF as compared to healthy controls (16.4 pg/mL vs. 5.8 pg/mL and 15.4 pg/mL vs. 14.5 pg/mL, respectively). However, plasma HNPs levels were relatively unchanged. HNP and IL-8 levels in patient BALF displayed a significant positive correlation significantly correlated (r = 0.774, p <0.01), and which also correlated with clinical disease parameters--such as ILD biomarkers, pulmonary function tests, ratio of neutrophils and eosinophils in BALF, tricuspid regurgitation peak gradient (TRPG), and the extent of high-resolution computed tomography (HRCT) findings in the lung. Levels of plasma HNPs and serum IL-8 did not show a significant correlation with any clinical parameter. SSc-ILD progression was evaluated by pulmonary function tests, but no association was observed between VC change ratios and HNPs or IL-8 levels.

CONCLUSIONS

BALF levels of HNPs and IL-8 were higher in SSc-ILD than in healthy controls, and are associated with various clinical disease parameters. Further studies are needed to clarify the role of defensins and IL-8 in SSc-ILD pathogenesis.

摘要

背景

间质性肺病(ILD)是系统性硬化症(SSc)患者的主要死亡原因。尽管SSc-ILD的发病机制尚未完全明确,但中性粒细胞可能在此过程中起关键作用。中性粒细胞储存嗜天青颗粒,其中含有防御素(一种在调节炎症反应中起作用的抗菌肽)和白细胞介素-8(IL-8,一种对中性粒细胞有强效趋化作用的物质)。本研究评估了SSc-ILD患者体内防御素和IL-8的水平,以确定它们在疾病发病机制中的作用。

方法

采用酶联免疫吸附测定法(ELISA),检测了33例SSc-ILD患者及20名健康对照者血清和支气管肺泡灌洗液(BALF)中的防御素(也称为人中性粒细胞肽,HNPs)和IL-8水平。

结果

BALF分析显示,SSc-ILD患者的HNPs水平(中位数为240.0 pg/mL)显著高于健康对照者(79.7 pg/mL)。此外,与健康对照者相比,SSc-ILD患者血清和BALF中的IL-8水平更高(分别为16.4 pg/mL对5.8 pg/mL和15.4 pg/mL对14.5 pg/mL)。然而,血浆中HNPs水平相对未变。患者BALF中的HNP和IL-8水平呈显著正相关(r = 0.774,p <0.01),且与临床疾病参数相关,如ILD生物标志物、肺功能测试、BALF中中性粒细胞与嗜酸性粒细胞的比例、三尖瓣反流峰值梯度(TRPG)以及肺部高分辨率计算机断层扫描(HRCT)结果的范围。血浆HNPs水平和血清IL-8水平与任何临床参数均无显著相关性。通过肺功能测试评估SSc-ILD的进展情况,但未观察到肺活量(VC)变化率与HNPs或IL-8水平之间存在关联。

结论

SSc-ILD患者BALF中的HNPs和IL-8水平高于健康对照者,且与多种临床疾病参数相关。需要进一步研究以阐明防御素和IL-8在SSc-ILD发病机制中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af05/4676113/8e414959af0f/12931_2015_308_Fig1_HTML.jpg

相似文献

3
Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
Int J Rheum Dis. 2014 Jul;17(6):664-70. doi: 10.1111/1756-185X.12290. Epub 2014 Jan 28.
5
Elevated plasma α-defensins in patients with acute exacerbation of fibrotic interstitial pneumonia.
Respir Med. 2015 Feb;109(2):265-71. doi: 10.1016/j.rmed.2014.12.015. Epub 2015 Jan 7.
6
Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Rheumatol Int. 2018 May;38(5):813-819. doi: 10.1007/s00296-018-3987-3. Epub 2018 Feb 17.
8
Serum cytokines and their predictive value in pulmonary involvement of systemic sclerosis.
Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(4):274-284. doi: 10.36141/svdld.v36i4.7612. Epub 2019 May 1.

引用本文的文献

7
Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease.
Eur Respir Rev. 2018 May 15;27(148). doi: 10.1183/16000617.0102-2017. Print 2018 Jun 30.
9
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial.
EBioMedicine. 2017 Nov;25:112-121. doi: 10.1016/j.ebiom.2017.10.018. Epub 2017 Oct 24.

本文引用的文献

1
Elevated plasma α-defensins in patients with acute exacerbation of fibrotic interstitial pneumonia.
Respir Med. 2015 Feb;109(2):265-71. doi: 10.1016/j.rmed.2014.12.015. Epub 2015 Jan 7.
3
Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.
Curr Rheumatol Rep. 2014 Apr;16(4):411. doi: 10.1007/s11926-014-0411-1.
4
Recent advances in the field of antimicrobial peptides in inflammatory diseases.
Adv Biomed Res. 2013 Jun 29;2:50. doi: 10.4103/2277-9175.114192. eCollection 2013.
6
Scleroderma lung disease.
Eur Respir Rev. 2013 Mar 1;22(127):6-19. doi: 10.1183/09059180.00005512.
8
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease.
Clin Respir J. 2012 Jan;6(1):9-17. doi: 10.1111/j.1752-699X.2010.00228.x. Epub 2010 Nov 25.
10
An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis.
Ann Rheum Dis. 2011 Jun;70(6):1115-21. doi: 10.1136/ard.2010.137349. Epub 2011 Feb 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验